Literature DB >> 8336516

Hepatocyte growth factor enhances B-cell activity.

B Delaney1, W S Koh, K H Yang, S C Strom, N E Kaminski.   

Abstract

Hepatocyte growth factor (HGF), is one of the growth factors induced and secreted into the serum of partially hepatectomized or hepatotoxin-treated mice that mediates regeneration of hepatic tissue. Results are presented here demonstrating that in addition to hepatotrophic effects, HGF also possesses immunologic activity. In particular, addition of HGF to B6C3F1 mouse spleen cell cultures enhanced humoral immune responses by augmenting the ability of B-cells to secrete immunoglobulin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8336516     DOI: 10.1016/0024-3205(93)90654-l

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  The role of hepatocyte growth factor and its receptor c-met in interactions between lymphocytes and stromal cells in secondary human lymphoid organs.

Authors:  G Skibinski; A Skibinska; K James
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

2.  Expression of HGF mRNA in human rejecting kidney as evidenced by in situ hybridization.

Authors:  K Yamaguchi; M A Nalesnik; G K Michalopoulos
Journal:  Urol Res       Date:  1996

3.  c-Met and its ligand hepatocyte growth factor/scatter factor regulate mature B cell survival in a pathway induced by CD74.

Authors:  Maya Gordin; Melania Tesio; Sivan Cohen; Yael Gore; Frida Lantner; Lin Leng; Richard Bucala; Idit Shachar
Journal:  J Immunol       Date:  2010-07-16       Impact factor: 5.422

4.  Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway.

Authors:  R van der Voort; T E Taher; R M Keehnen; L Smit; M Groenink; S T Pals
Journal:  J Exp Med       Date:  1997-06-16       Impact factor: 14.307

Review 5.  Immune interactions in hepatic fibrosis.

Authors:  Andrew P Holt; Mike Salmon; Christopher D Buckley; David H Adams
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.